Search

everythinglearnresearchcommunity

for

Search:↓

Most people in Turkey start getting gray hair around 33 years old, with factors like age, education, hair loss, skin type, family history, and anxiety playing a role.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Obese women with PCOS are more likely to have fatty liver disease.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

PRP injections can effectively treat alopecia areata.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

The Princeton III Consensus recommends assessing cardiovascular risk in men with erectile dysfunction and prioritizing heart health before treating ED, especially in those with potential heart disease.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Some birth control pills increase young women's risk of blood clots more than others.